BRAIN IRON AND FERRITIN IN PARKINSONS AND ALZHEIMERS DISEASES

被引:403
作者
JELLINGER, K
PAULUS, W
GRUNDKEIQBAL, I
RIEDERER, P
YOUDIM, MBH
机构
[1] NEW YORK STATE INST BASIC RES DEV DISABILITIES,STATEN ISL,NY 10314
[2] UNIV WURZBURG,SCH MED,DEPT PSYCHIAT,W-8700 WURZBURG,GERMANY
[3] TECHNION ISRAEL INST TECHNOL,DEPT PHARMACOL,HAIFA,ISRAEL
关键词
IRON; FERRITIN; PARKINSONS DISEASE; ALZHEIMERS DISEASE; MELANIN; LEWY BODY;
D O I
10.1007/BF02252926
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Semiquantitative histological evaluation of brain iron and ferritin in Parkinson's (PD) and Alzheimer's disease (DAT) have been performed in paraffin sections of brain regions which included frontal cortex, hippocampus, basal ganglia and brain stem. The results indicate a significant selective increase of Fe3+ and ferritin in substantia nigra zona compacta but not in zona reticulata of Parkinsonian brains, confirming the biochemical estimation of iron. No such changes were observed in the same regions of DAT brains. The increase of iron is evident in astrocytes, macrophages, reactive microglia and non-pigmented neurons, and in damaged areas devoid of pigmented neurons. In substantia nigra of PD and PD/DAT, strong ferritin reactivity was also associated with proliferated microglia. A faint iron staining was seen occasionally in peripheral halo of Lewy bodies. By contrast, in DAT and PD/DAT, strong ferritin immunoreactivity was observed in and around senile plaques and neurofibrillary tangles. The interrelationship between selective increase of iron and ferritin in PD requires further investigation, because both changes could participate in the induction of oxidative stress and neuronal death, due to their ability to promote formation of oxygen radicals.
引用
收藏
页码:327 / 340
页数:14
相关论文
共 55 条
[1]   POSTMORTEM DISTRIBUTION OF DOPAMINE AND HOMOVANILLIC-ACID IN HUMAN-BRAIN, VARIATIONS RELATED TO AGE, AND A REVIEW OF THE LITERATURE [J].
ADOLFSSON, R ;
GOTTFRIES, CG ;
ROOS, BE ;
WINBLAD, B .
JOURNAL OF NEURAL TRANSMISSION, 1979, 45 (02) :81-105
[2]   BRAIN PEROXIDASE AND CATALASE IN PARKINSON DISEASE [J].
AMBANI, LM ;
VANWOERT, MH ;
MURPHY, S .
ARCHIVES OF NEUROLOGY, 1975, 32 (02) :114-118
[3]   LONG-TERM CONSEQUENCE OF EARLY IRON-DEFICIENCY ON DOPAMINERGIC NEUROTRANSMISSION IN RATS [J].
BENSHACHAR, D ;
ASHKENAZI, R ;
YOUDIM, MBH .
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 1986, 4 (01) :81-88
[4]  
BURNS RS, 1984, CAN J NEUROL SCI, V11, P166
[5]   IRON-RESPONSIVE ELEMENTS - REGULATORY RNA SEQUENCES THAT CONTROL MESSENGER-RNA LEVELS AND TRANSLATION [J].
CASEY, JL ;
HENTZE, MW ;
KOELLER, DM ;
CAUGHMAN, SW ;
ROUAULT, TA ;
KLAUSNER, RD ;
HARFORD, JB .
SCIENCE, 1988, 240 (4854) :924-928
[6]   T2 VALUES IN THE HUMAN-BRAIN - COMPARISON WITH QUANTITATIVE ASSAYS OF IRON AND FERRITIN [J].
CHEN, JC ;
HARDY, PA ;
CLAUBERG, M ;
JOSHI, JG ;
PARRAVANO, J ;
DECK, JHN ;
HENKELMAN, RM ;
BECKER, LE ;
KUCHARCZYK, W .
RADIOLOGY, 1989, 173 (02) :521-526
[7]   CHRONIC PARKINSONISM SECONDARY TO INTRAVENOUS-INJECTION OF MEPERIDINE ANALOGS [J].
DAVIS, GC ;
WILLIAMS, AC ;
MARKEY, SP ;
EBERT, MH ;
CAINE, ED ;
REICHERT, CM ;
KOPIN, IJ .
PSYCHIATRY RESEARCH, 1979, 1 (03) :249-254
[8]  
DEXTER DT, 1987, LANCET, V2, P1219
[9]   INCREASED NIGRAL IRON CONTENT AND ALTERATIONS IN OTHER METAL-IONS OCCURRING IN BRAIN IN PARKINSONS-DISEASE [J].
DEXTER, DT ;
WELLS, FR ;
LEES, AJ ;
AGID, F ;
AGID, Y ;
JENNER, P ;
MARSDEN, CD .
JOURNAL OF NEUROCHEMISTRY, 1989, 52 (06) :1830-1836
[10]   BASAL LIPID-PEROXIDATION IN SUBSTANTIA NIGRA IS INCREASED IN PARKINSONS-DISEASE [J].
DEXTER, DT ;
CARTER, CJ ;
WELLS, FR ;
JAVOYAGID, F ;
AGID, Y ;
LEES, A ;
JENNER, P ;
MARSDEN, CD .
JOURNAL OF NEUROCHEMISTRY, 1989, 52 (02) :381-389